These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30946043)

  • 1. Recurrent Suicidal Ideation During Intravenous Ketamine Treatment.
    Smith AWT; Virk S
    Am J Ther; 2019; 26(6):e732-e735. PubMed ID: 30946043
    [No Abstract]   [Full Text] [Related]  

  • 2. Urgent ketamine infusion rapidly eliminated suicidal ideation for a patient with major depressive disorder: a case report.
    Zigman D; Blier P
    J Clin Psychopharmacol; 2013 Apr; 33(2):270-2. PubMed ID: 23422387
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.
    Ionescu DF; Swee MB; Pavone KJ; Taylor N; Akeju O; Baer L; Nyer M; Cassano P; Mischoulon D; Alpert JE; Brown EN; Nock MK; Fava M; Cusin C
    J Clin Psychiatry; 2016 Jun; 77(6):e719-25. PubMed ID: 27232360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous Ketamine as an Effective and Safe Treatment in a Suicidal Patient With Cancer Who Was Nil Per Os.
    Rajagukguk S; Lee T
    Psychosomatics; 2020; 61(4):371-374. PubMed ID: 31739996
    [No Abstract]   [Full Text] [Related]  

  • 5. Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients.
    Chen X; Wang M; Hu Y; Zhan Y; Zhou Y; Zheng W; Liu W; Wang C; Zhong X; Li H; Lan X; Ning Y; Zhang B
    Eur Arch Psychiatry Clin Neurosci; 2021 Apr; 271(3):431-438. PubMed ID: 33386430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
    Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP
    J Psychiatr Res; 2018 Nov; 106():61-68. PubMed ID: 30278319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
    Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C
    J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid Receptor μ-1 and Ketamine Effects in a Suicidal Depression Trial: A Post Hoc Exploration.
    Grunebaum MF; Galfalvy HC; Liu J; Huang YY; Marcott S; Burke AK; Mann JJ
    J Clin Psychopharmacol; 2020; 40(4):420-422. PubMed ID: 32590406
    [No Abstract]   [Full Text] [Related]  

  • 9. Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder.
    Niciu MJ; Grunschel BD; Corlett PR; Pittenger C; Bloch MH
    J Psychopharmacol; 2013 Jul; 27(7):651-4. PubMed ID: 23676198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuation phase intravenous ketamine in adults with treatment-resistant depression.
    Vande Voort JL; Morgan RJ; Kung S; Rasmussen KG; Rico J; Palmer BA; Schak KM; Tye SJ; Ritter MJ; Frye MA; Bobo WV
    J Affect Disord; 2016 Dec; 206():300-304. PubMed ID: 27656788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new indication for esketamine nasal spray (Spravato).
    Med Lett Drugs Ther; 2020 Sep; 62(1607):151. PubMed ID: 32960869
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical predictive factors and trajectories of suicidal remission over 6 weeks following intravenous ketamine for suicidal ideation.
    Jollant F; Demattei C; Fabbro P; Abbar M
    J Affect Disord; 2024 Feb; 347():1-7. PubMed ID: 37981038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of a Rapid Intravenous Injection of Ketamine 0.5 mg/kg in Treatment-Resistant Major Depression: An Open 4-Week Longitudinal Study.
    Vidal S; Gex-Fabry M; Bancila V; Michalopoulos G; Warrot D; Jermann F; Dayer A; Sterpenich V; Schwartz S; Vutskits L; Khan N; Aubry JM; Kosel M
    J Clin Psychopharmacol; 2018 Dec; 38(6):590-597. PubMed ID: 30346333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Ketamine in Severe Depression with suicidal ideation - Insights from a Case Study.
    Gurnani T; Khurshid KA
    Asian J Psychiatr; 2017 Oct; 29():112-113. PubMed ID: 29061405
    [No Abstract]   [Full Text] [Related]  

  • 15. Ketamine infusion as a treatment for major depressive disorder: a new role for anesthesiologists?
    Dilley JD; Gentry WB; Golden KJ
    Middle East J Anaesthesiol; 2012 Oct; 21(6):871-3. PubMed ID: 23634571
    [No Abstract]   [Full Text] [Related]  

  • 16. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.
    Murrough JW; Soleimani L; DeWilde KE; Collins KA; Lapidus KA; Iacoviello BM; Lener M; Kautz M; Kim J; Stern JB; Price RB; Perez AM; Brallier JW; Rodriguez GJ; Goodman WK; Iosifescu DV; Charney DS
    Psychol Med; 2015 Dec; 45(16):3571-80. PubMed ID: 26266877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in Suicidal Ideation Following Repeated Doses of Intravenous Ketamine?
    Apeldoorn SY; de Boer MK; Schoevers RA
    J Clin Psychiatry; 2017 Jan; 78(1):e71. PubMed ID: 28129500
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment-resistant bipolar disorder managed with ketamine infusions as monotherapy.
    Mouwen A; Walsh S
    JAAPA; 2021 Dec; 34(12):1. PubMed ID: 34813557
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of ketamine on major depressive disorder in a patient with posttraumatic stress disorder.
    Womble AL
    AANA J; 2013 Apr; 81(2):118-9. PubMed ID: 23971230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department.
    Larkin GL; Beautrais AL
    Int J Neuropsychopharmacol; 2011 Sep; 14(8):1127-31. PubMed ID: 21557878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.